Swiss-EU success stories

In March 2021, the EU-funded biotech company Gain Therapeutics successfully entered the NASDAQ stock market. We had the opportunity to chat with the president.

Since October 2019, the EU-funded project WiPLASH is delivering on disruptive wireless on-chip communication. And Swiss knowledge is a crucial part of it.

Founder of the Swiss biotech company AMAL Therapeutics received the Women Innovator’s Prize for her cancer vaccine research.

IBM’s Zurich lab leads effort to solve a major challenge for the next generation of IoT devices, computers and supercomputers: reducing energy consumption.

“The strongest driver for change is a motivated person”, says the Managing Director of the newly inaugurated ETH AI Centre, Dr. Alexander Ilic.

The innovative and sustainable start-up Vatorex has developed a chemical-free solution for saving bees and received €1.6m from the Horizon 2020 programme.

A capacity building scheme between Switzerland and Croatia is connecting Croatian research and innovation intensive companies with cross-border value chains.

A tenure track programme between Switzerland and Croatia giving young researchers the opportunity to lead an own research group helps tackle brain drain.

The KEEN project supports Kaunas University of Technology in becoming an entrepreneurial R&I excellence hub. Also on board is the University of St Gallen.

Experimental immunologist Ondrej Štěpánek holds a prestigious ERC grant, building on a unique Swiss fund for Eastern European scientists.